Swart JF, de Roock S, Nievelstein RJ, et al. Safety and efficacy of intravenous administration of bone-marrow derived mesenchymal stromal cells in therapy refractory juvenile idiopathic arthritis patients, a phase ib/iia pilot-study. EULAR 2018. Abstract OP0203.
Bimekizumab bij actieve axSpA: effectiviteit en veiligheid over 52 weken
jan 2024 | Spondyloartritis